Breaking
Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect ProgramEli Lilly's Legal Victory Over Noom's GLP-1 ClaimsBBSW AI Solution Event: Daily Roundup
Saturday, July 11, 2026
🇺🇸 FDA

tabelecleucel News

🇺🇸 FDA ← All news

FDA tabelecleucel coverage for business development, investment, and market access teams

High impact NewsMay 2, 2026

Atara Biotherapeutics Receives FDA Complete Response Letter for EBVALLO Cancer Treatment, Faces Securities Class Action

Oncology - Post-transplant lymphoproliferative disease · 3 min

James Chen, PharmD
High impact NewsApr 23, 2026

FDA Issues Complete Response Letter for Atara Biotherapeutics' EBVALLO Cancer Treatment, Triggering Securities Lawsuit

Oncology - Post-transplant lymphoproliferative disease · 3 min

Daniel Brooks

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.